Genetic framework for GATA factor function in vascular biology

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 33, 2011, Pages 13641-13646

  Linnemann, Amelia K ^a   O'Geen, Henriette ^b   Keles, Sunduz ^c   Farnham, Peggy J ^d   Bresnick, Emery H ^a  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Endothelium; Genome wide; Genomics; Transcriptome

Indexed keywords

HETERODIMER; PROTEIN C FOS; PROTEIN C JUN; SERINE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 2;

ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ERYTHROID CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; VASCULAR BIOLOGY;

CHROMATIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ERYTHROID CELLS; GATA2 TRANSCRIPTION FACTOR; GENE REGULATORY NETWORKS; GENES, FOS; GENES, JUN; HUMANS; INFLAMMATION; TRANSCRIPTION FACTOR AP-1;

EID: 80051995505     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1108440108     Document Type: Article

References (57)

1. De Val S., Black B.L. (2009) Transcriptional control of endothelial cell development. Dev Cell 16:180-195.
2. Tsai F-Y, Orkin S.H. (1997) Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:3636-3643. (Pubitemid 27227086)
3. Tsai F.Y., et al. (1994) An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221-226.
4. Bresnick E.H., Lee H.Y., Fujiwara T., Johnson K.D., Keles S. (2010) GATA switches as developmental drivers. J Biol Chem 285:31087-31093.
5. Dorfman D.M., Wilson D.B., Bruns G.A., Orkin S.H. (1992) Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 267:1279-1285.
6. Lee M.E., Temizer D.H., Clifford J.A., Quertermous T. (1991) Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 266:16188-16192. (Pubitemid 21907782)
7. Connelly J.J., et al. (2006) GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet 2:e139.
8. Simon M.P., Tournaire R., Pouyssegur J. (2008) The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 217:809-818.
9. Han X., Boyd P.J., Colgan S., Madri J.A., Haas T.L. (2003) Transcriptional up-regulation of endothelial cell matrix metalloproteinase-2 in response to extracellular cues involves GATA-2. J Biol Chem 278:47785-47791. (Pubitemid 37523225)
10. Minami T., Aird W.C. (2001) Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs. J Biol Chem 276:47632-47641.
11. Mammoto A., et al. (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457:1103-1108.
12. Fujiwara T., et al. (2009) Discovering hematopoietic mechanisms through genomewide analysis of GATA factor chromatin occupancy. Mol Cell 36:667-681.
13. KarinM., Liu Z., Zandi E. (1997) AP-1 function and regulation. Curr Opin Cell Biol 9:240-246. (Pubitemid 27135992)
14. Wagner E.F., Eferl R. (2005) Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208:126-140. (Pubitemid 41746389)
15. Pober J.S., Sessa W.C. (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803-815. (Pubitemid 47480307)
16. Grass J.A., et al. (2006) Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol 26:7056-7067. (Pubitemid 44477685)
17. Wozniak R.J., Boyer M.E., Grass J.A., Lee Y-S, Bresnick E.H. (2007) Context-dependent GATA factor function: Combinatorial requirements for transcriptional control in hematopoietic and endothelial cells. J Biol Chem 282:14665-14674. (Pubitemid 47100419)
18. SenBanerjee S., et al. (2004) KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199:1305-1315. (Pubitemid 38685723)
19. Lee J.S., et al. (2006) Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell 11:845-857. (Pubitemid 44804271)
20. Lin Z., et al. (2005) Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96:e48-e57.
21. Wu J., Bohanan C.S., Neumann J.C., Lingrel J.B. (2008) KLF2 transcription factor modulates blood vesselmaturation through smoothmuscle cellmigration. J Biol Chem 283:3942-3950.
22. Parmar K.M., et al. (2005) Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280:26714-26719. (Pubitemid 41040703)
23. Wang L.C., et al. (1997) Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J 16:4374-4383. (Pubitemid 27298190)
24. Wang L.C., et al. (1998) The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 12:2392-2402. (Pubitemid 28371358)
25. Lin Q., et al. (1998) Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125:4565-4574. (Pubitemid 28564299)
26. De Val S., et al. (2004) Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev Biol 275:424-434. (Pubitemid 40288096)
27. Barski A., et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129:823-837. (Pubitemid 46802390)
28. Santos-Rosa H., et al. (2002) Active genes are tri-methylated at K4 of histone H3. Nature 419:407-411.
29. Bembom O., Keles S., Van der Laan M.J. (2007) Supervised detection of conserved motifs in DNA sequences with cosmo. Stat Appl Genet Mol Biol 6(1): Article 8.
30. Bailey T.L., Williams N., Misleh C., Li W.W. (2006) MEME: Discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res 34(Web Server issue):W369-W373.
31. Zhan Y., et al. (2005) Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 115:2508-2516. (Pubitemid 41266213)
32. Angel P., et al. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739. (Pubitemid 18094763)
33. Yasumoto K., et al. (1992) Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J Biol Chem 267:22506-22511.
34. Faouzi S., et al. (2001) Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 276:49077-49082.
35. Wang C.Y., et al. (1994) Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol Cell Biol 14:1153-1159.
36. Serini G., Valdembri D., Bussolino F. (2006) Integrins and angiogenesis: A sticky business. Exp Cell Res 312:651-658. (Pubitemid 43290341)
37. Larrucea S., et al. (2008) Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp Cell Res 314:2004-2015.
38. Kazanskaya O., et al. (2008) The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development. Development 135:3655-3664.
39. Kawauchi J., et al. (2002) Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 277:39025-39034. (Pubitemid 35154769)
40. Gilchrist M., et al. (2008) Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation. J Exp Med 205:2349-2357.
41. Olive M., et al. (1997) A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J Biol Chem 272:18586-18594. (Pubitemid 27318198)
42. Gerdes M.J., et al. (2006) Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res 66:7578-7588. (Pubitemid 44289214)
43. Kawana M., Lee M.E., Quertermous E.E., Quertermous T. (1995) Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 15:4225-4231.
44. Lee E.G., et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350-2354.
45. Cooper J.T., et al. (1996) A20 blocks endothelial cell activation through a NF-kappaBdependent mechanism. J Biol Chem 271:18068-18073. (Pubitemid 26250793)
46. Natoli G. (2010) NF-kappaB: No longer an island, but a piece of a continent. EMBO Rep 11:246-248.
47. Bailey T.L., et al. (2009) MEME SUITE: Tools for motif discovery and searching. Nucleic Acids Res 37(Web Server issue):W202-8.
48. Song H., et al. (2009) Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. J Biol Chem 284:29109-29124.
49. Kanki Y., et al. (2011) Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression. EMBO J 30:2582-2595.
50. Eferl R., Wagner E.F. (2003) AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868. (Pubitemid 37383716)
51. Shaulian E., Karin M. (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136. (Pubitemid 34521026)
52. Kouros-Mehr H., et al. (2008) GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13:141-152. (Pubitemid 351163164)
53. Zhang S.J., et al. (2008) Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA 105:2076-2081.
54. Im H., et al. (2005) Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc Natl Acad Sci USA 102:17065-17070. (Pubitemid 41692684)
55. Im H., et al. (2004) Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol Biol 284:129-146.
56. O'Geen H., Frietze S., Farnham P.J. (2010) Using ChIP-seq technology to identify targets of zinc finger transcription factors. Methods Mol Biol 649:437-455.
57. Blahnik K.R., et al. (2010) Sole-Search: An integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res 38:e13.